Edition:
United Kingdom

Surgery Partners Inc (SGRY.OQ)

SGRY.OQ on NASDAQ Stock Exchange Global Select Market

17.48USD
18 Apr 2018
Change (% chg)

-- (--)
Prev Close
$17.48
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
106,053
52-wk High
$24.05
52-wk Low
$7.10

Summary

Name Age Since Current Position

T. Devin O'Reilly

2017 Chairman of the Board

Wayne DeVeydt

47 2018 Chief Executive Officer, Director

Thomas Cowhey

45 2018 Chief Financial Officer, Principal Accounting Officer

John Crysel

63 Group President of Surgery Partners’ National Group

Jennifer Baldock

47 Senior Vice President, General Counsel, Secretary

Dennis Dean

44 2015 Senior Vice President, Corporate Controller

R. David Kretschmer

59 2018 Chief Strategy and Transformation Officer

Clifford Adlerz

64 2018 Director

Teresa DeLuca

51 2016 Director

Christopher Gordon

2017 Director

Adam Feinstein

45 2015 Independent Director

Brent Turner

51 2015 Independent Director

Biographies

Name Description

T. Devin O'Reilly

Wayne DeVeydt

Mr. Wayne DeVeydt is Chief Executive Officer, Director of the Company. Mr. DeVeydt served as a Senior Advisor to the Global Healthcare division of Bain Capital Private Equity, LP, the investment advisor of BCPE Seminole Holdings LP, the Company’s controlling shareholder, from January 2017 until January 3, 2018. From May 2007 to May 2016, Mr. DeVeydt served as Executive Vice President and Chief Financial Officer of Anthem, Inc. (“Anthem”), a health insurance company. From March 2005 to May 2007, he served as Anthem’s Senior Vice President and Chief Accounting Officer and for a portion of that time, he also served as Chief of Staff to the Chairman and Chief Executive Officer. Prior to joining Anthem, Mr. DeVeydt served as an audit partner at PricewaterhouseCoopers LLP, focused on companies in the national managed care and insurance industries. Mr. DeVeydt currently serves as a director of NiSource Inc., a utilities company, and as a director of Myovant Sciences Ltd., a biopharmaceutical company, which roles he assumed in March 2016 and September 2016, respectively. Mr. DeVeydt received his B.S. in Business Administration from the University of Missouri in St. Louis.

Thomas Cowhey

Mr. Thomas F. Cowhey is Chief Financial Officer, Principal Accounting Officer of the Company, effective April 2, 2018. He joins the Company from Aetna, Inc, where he has served since 2007 with roles in treasury and corporate finance, corporate strategy and development, and financial responsibility. From 2016 to present, he served as the Chief Financial Officer of Aetna’s Institution Business portfolio. During 2016, he served as Chief Financial Officer of Aetna’s Consumer Health & Services portfolio, and from 2010 to 2016, Mr. Cowhey served as Vice President of Investor Relations and Business Development. Prior to his time at Aetna, Mr. Cowhey held a variety of financial management and banking roles. Mr. Cowhey received his B.S. degree in economics from Wesleyan University and an M.B.A. degree with a concentration in health sector management from Duke University.

John Crysel

Mr. John B. Crysel serves as Group President of Surgery Partners’ National Group of the company. Mr. Crysel previously served as National Group President of Symbion. Prior to joining Symbion in 2011, he served in a variety of hospital management positions with Hospital Corporation of America and HealthTrust in addition to pursuing various healthcare investment interests. Mr. Crysel holds a B.S. in Business Administration from the University of Alabama and an MSHA from the University of Alabama at Birmingham.

Jennifer Baldock

Ms. Jennifer Boyd Baldock serves as Senior Vice President, General Counsel, Secretary of the company. Ms. Baldock previously served as General Counsel and Chief Compliance Officer of Symbion Holdings Corporation and Symbion, Inc. Prior to joining Symbion in 2010, she served as Assistant General Counsel for both Ambulatory Services of America and Renal Care Group. Prior to that, Ms. Baldock practiced law with Waller Lansden Dortch and Davis in Nashville, Tennessee, concentrating in corporate law with an emphasis on healthcare mergers and acquisitions. She is also a Certified Public Accountant (inactive). Ms. Baldock holds a Bachelor of Arts in Economics and Accounting from Lipscomb University and a Juris Doctor from the University of Alabama.

Dennis Dean

Mr. Dennis Dean serves as Senior Vice President, Corporate Controller of the company. Mr. Dean previously served as Vice President and Corporate Controller of Symbion Holdings Corporation and Symbion, Inc. from January 2008 to November 2014. Prior to joining Symbion, he co-founded Resource Partners, LLC, a healthcare-focused financial consulting firm, and began his career at Deloitte & Touche LLP. He is also a Certified Public Accountant. Mr. Dean holds a B.S. in Accounting and an MAcc from Western Kentucky University.

R. David Kretschmer

Mr. R. David Kretschmer is Chief Strategy and Transformation Officer of the Company. He joins Surgery Partners from Anthem, Inc. (“Anthem”), where he most recently served as Senior Vice President of Treasury and Corporate Strategy. From February 1991 to February 2018, Mr. Kretschmer held many responsibilities at Anthem, including treasury and corporate finance activities, enterprise risk management, corporate strategy and development, cash collections and disbursements, and management of Anthem’s $24 billion investment portfolio. Prior to his time at Anthem, Mr. Kretschmer held a variety of financial management and corporate finance roles. Mr. Kretschmer will begin his new roles at Surgery Partners on February 12, 2018. Mr. Kretschmer received his B.S. in Business from the George Washington University and his M.B.A. from the University in Chicago.

Clifford Adlerz

Mr. Clifford G. Adlerz is Director of the company. He is currently provides consulting services to Bain Capital Private Equity, LP. Prior to this, Mr. Adlerz served as President of Symbion, Inc. (“Symbion”), a multi-specialty provider of ambulatory surgery centers and hospitals, from May 2002 until the Company’s acquisition of Symbion in November 2014. Mr. Adlerz also served as Chief Operating Officer of Symbion from 1996 to 2002 and as director of Symbion from 1996 to 2014. Mr. Adlerz served as Regional Vice President, Midsouth Region for HealthTrust, Inc. from 1992 until its merger with HCA Inc. (“HCA”), a healthcare facilities operator, in May 1995, after which time he served as Division Vice President of HCA until September 1995. Mr. Adlerz holds a B.A. in Business and an M.B.A. from the University of Florida.

Teresa DeLuca

Dr. Teresa DeLuca, M.D. serves as Director of the Company. Dr. DeLuca is an Assistant Clinical professor of psychiatry at the Icahn School of Medicine at Mount Sinai in New York City and serves on the editorial board of the American Health & Drug Benefit Journal. She was previously the Chief Medical Officer of Magellan Pharmacy Solutions at Magellan Health, SVP of Pharmacy Health Solutions at Humana, VP of Clinical Sales Solutions & National Medical Director at Walgreen Co., and VP of Personalized Medicine as well as VP of Medical Policy & Clinical Quality at Medco. Prior to taking on these executive leadership roles, Dr. DeLuca was a Senior Director of Global Product Development Services at PRA International and a Senior Medical Scientist at GlaxoSmithKline. Dr. DeLuca received her M.B.A. from Drexel University and her residency (M.D.) from Jefferson Medical College of Thomas Jefferson University.

Christopher Gordon

Adam Feinstein

Mr. Adam Feinstein serves as Independent Director of the company. Mr. Feinstein co-founded Vesey Street Capital Partners, L.L.C., a healthcare services private equity fund, in 2014 and has been a Managing Partner since that time. From 2012 to 2014, Mr. Feinstein served as the Senior Vice President of Corporate Development, Strategic Planning and Office of the CEO at LabCorp and prior to that served as a Managing Director in Equity Research at Barclays Capital. He is a board member at ScribeAmerica, the nation’s leading provider of medical scribes, and Imedex, a leading provider of accredited medical education. Mr. Feinstein is a CFA charterholder and has a B.S. in Business from the Smith School at the University of Maryland at College Park. He also completed the Nashville Healthcare Council Fellows program.

Brent Turner

Mr. Brent Turner serves as Independent Director of the Company. Mr. Turner has served as Director of Surgery Partners, Inc. since December 2015. Mr. Turner is currently the President of Acadia Healthcare Company Inc (NASDAQ: ACHC), and has served as the President since joining Acadia in 2011. Prior to joining Acadia, Mr. Turner served as the Executive Vice President of Finance and Administration of Psychiatric Solutions, Inc. Mr. Turner serves on the Board of Directors of LHC Group, Inc. (NASDAQ: LHCG) and the National Association of Psychiatric Health Systems (NAPHS). Mr. Turner holds a B.A. in Economics from Vanderbilt University and an M.B.A. from the Vanderbilt Owen Graduate School of Management.